CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus
โ Scribed by Shunji Morita; Masahiko Yano; Hitoshi Shiozaki; Toshimasa Tsujinaka; Chikara Ebisui; Takashi Morimoto; Masanori Kishibuti; Junya Fujita; Atsuhiro Ogawa; Masaaki Taniguchi; Masatoshi Inoue; Shigeyuki Tamura; Keiji Yamazaki; Nobuteru Kikkawa; Sumio Mizunoya; Morito Monden
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- French
- Weight
- 43 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
We investigated the genetic polymorphisms of CYP1A1, CYP2E1 and GSTM1 in Japanese esophageal cancer patients (n = 53) with a histological diagnosis of squamous-cell carcinoma, to determine whether susceptibility to esophageal cancer is associated with these polymorphisms. There were no significant differences in the frequency distribution of any one of the 3 polymorphisms between esophageal cancer patients and 132 healthy Japanese controls. The genotype distributions in tobacco smokers or alcohol drinkers were also quite similar for male patients and male controls. The age at onset of esophageal cancer was also similar for patients with any genotype of the 3 polymorphisms. We conclude that the 3 polymorphisms are unlikely to be associated with esophageal cancer susceptibility.
๐ SIMILAR VOLUMES
The authors established the genotype frequencies of cytochrome P450 (CYP1A1/MspI, CYP2E1/PstI, and CYP2E1/DraI), glutathione-S-transferase (GSTM1 and GSTT1), and p53 (exon 4/AccII and intron 3/16-base pair duplication) gene polymorphisms in cervical carcinoma patients and controls and evaluated the
thione-S-transferases. A high risk lung carcinoma group has been reported to have specific polymorphisms of the cytochrome P450 (CYP1A1) gene and the glutathi-
We examined the effect of genetic polymorphisms of phase-II enzymes, glutathione S-transferase P1 (GSTP1) and N-acetyltrans-ferase2 (NAT2) on susceptibility to esophageal squamous-cell carcinoma. To determine the genotypes of the 2 polymorphisms, PCR-based analysis was performed on samples from 66 J